2017, Number 1
<< Back Next >>
Gac Med Mex 2017; 153 (1)
Effectiveness of intravenous sedation with midazolam-diphenhydramine in patients who are going to perform an magnetic resonance
Álvarez-Bastidas L, Sabag-Ruiz E, Medina-Soto A
Language: Spanish
References: 10
Page: 57-60
PDF size: 63.81 Kb.
ABSTRACT
Introduction: The requirement of the anesthesiologist for patient care outside the surgical area is constantly increasing.
It is an activity that encompasses the different degrees of monitoring, sedation, and anesthesia.
Objective: To compare
the safety and efficacy of midazolam midazolam-diphenhydramine against magnetic resonance with level of sedation on the
Ramsay scale.
Materials and methods: We performed a study in the Instituto Mexicano del Seguro Social Obregon, Sonora,
of patients scheduled for cranial magnetic resonance imaging with sedation, during October and December 2013,
comparing two groups: midazolam/diphenhydramine against midazolam groups.
Results: We included 68 patients, 34 in the
experimental group (midazolam-diphenhydramine) versus 34 controls (midazolam). The Ramsay scale showed, in the experimental group, an increased sedation effect resulting in one Ramsay 1, at 10 minutes 2.8 2.8 20 minutes and 30 minutes
2.0. In the control group the basal Ramsay was 1, 2.1 to 10 minutes, 20 minutes and 2.1 to 2.0 at 30 minutes (p = 0.0001).
The analysis of heart rate, respiratory, and baseline oxygen saturation, at 10, 20 and 30 minutes, was p = 0.0001 for both
groups.
Conclusion: The combination of diphenhydramine with intravenous midazolam is safe, with the degree of sedation
being better compared with use of midazolam alone, resulting in less failure of sedation during magnetic resonance imaging.
REFERENCES
Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol 2001;63:637-72.
García SMJ, López-Aldrete JA, Martín RJL, Prieto CM. Sedación en pacientes en las técnicas dolorosas diagnosticada y terapéutica: supuestos clínicos. Presentado en: V Reunión Científica de la SED y Jornada de actualización del dolor. Granada; 2001. p. 6-23.
Hernández-De la Vega L. Sedación consciente e inconsciente. Rev Mex Anest. 2004;27(Supl 1):395-497.
Tu RH, Grewall P, Leung JW, Suryaprasad AG. Diphenhydramine as adjunct to sedation for colonoscopy: a double-blind randomized, placebo- controlled study. Gastrointest Endosc. 2006;63:87-94.
Fernández AS, Navarrete ZV, Vallongo MMB, López RM, De la Barrera F. Midazolam-ketaminapropofol vs propofol para sedación en RMN. Costos y beneficios. Rev Cub Anest Rean. 2007;6:20-33.
Cengiz M, Baysal Z, Ganidaglis S. Oral sedation with midazolam and diphenhydramine compared with midazolam alone in children undergoing magnetic resonance imaging. Paediatr Anaesth. 2006;16: 621-6.
Roehrs T, Zwyghuizen-Doorenbos A, Roth T. Sedative effects and plasma concentrations following single doses of triazolam diphenhydramine, ethanol and placebo. Sleep. 1993;16:301-5.
Asamblea Mundial de Lisboa. Declaración de Lisboa de la AMM sobre los derechos del paciente. [En línea]. Portugal: WMA. 2005. (Consultado el 11 de julio de 2013.) Disponible en: http://www.wma.net/es/30publications/ 10policies/l4/index.html.pdf?print-media-type&footer-right- =[page]/[toPage]
Committee on Drugs. American Academy of Pediatrics. Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: addendum. Pediatrics. 2002;110:836-8.
Lawson GR. Controversy: sedation of children for magnetic resonance imaging. Arch Dis Child. 2000;82:150-3.